Comparing the current results to its competitors, Neuronetics Inc reported Revenue increase in the 1 quarter 2026 by 7.61 % year on year. The revenue growth was below Neuronetics Inc 's competitors' average revenue growth of 13.11 %, achieved in the same quarter.
Neuronetics Inc 's Comment on Competition and Industry Peers
Greenbrook operates in a fragmented market for transcranial magnetic stimulation (TMS) therapy, competing with companies such as Brainsway, Apollo TMS, Magstim, MagVenture, CloudTMS, and Nexstim, all of which offer alternatives to the NeuroStar Advanced Therapy System. The company also faces competition from pharmaceutical firms developing antidepressant medications and other neurohealth products, as well as from other physician practice management companies and individual medical practitioners. Additionally, emerging treatment modalities may impact Greenbrook's competitive position. The company identifies a significant shortage of mental healthcare providers in the United States.
September 16, 2024
Revolutionizing Mental Health Care: NeuroStar s Commitment to Patient-Centric Solutions In a groundbreaking advancement for mental health care, NeuroStar, a leader in transcranial magnetic stimulation (TMS) therapy, has recently announced a suite of software upgrades designed to enhance patient care across multiple dimensions. These upgrades focus on improving communication pathways, streamlining data management, and fortifying security measures all crucial elements in today s healthcare landscape, where patient data integrity and responsiveness can significantly affect treatment outcomes.The software enhancements come at a time when many health care providers are seeking robust solutions that ensure both ef...
August 1, 2024
In an era marked by increasing mental health concerns among adolescents, a significant partnership has emerged between NeuroStar and This Is My Brave, aimed at amplifying awareness and resources for teen mental health. As Teen Mental Health Month takes center stage, this initiative seeks to address the urgent and pressing need for accessible mental health information and support for young people navigating increasingly complex emotional landscapes. The Rising Tide of Teen Mental Health IssuesThe past few years have witnessed a worrying escalation in mental health challenges among teenagers. Factors such as the pervasive impact of social media, the aftermath of the COVID-19 pandemic, academic pressures, and s...
July 10, 2024
BlueCross BlueShield of Michigan and Cambia Health Solutions Expand TMS Access for Adolescents with Depression Post-FDA Clearance In a pivotal move aimed at addressing the rising mental health challenges faced by adolescents, BlueCross BlueShield of Michigan (BCBSM) and Cambia Health Solutions have expanded access to Transcranial Magnetic Stimulation (TMS) therapy a groundbreaking step for the mental health community. This initiative follows the U.S. Food and Drug Administration s (FDA) recent clearance of NeuroStar Advanced Therapy for pediatric use, specifically targeting adolescents grappling with treatment-resistant depression. Expanded TMS Coverage: A Response to Rising Adolescent Depression RatesThe me...
March 7, 2024
Neuronetics Partners with Transformations Care Network to Expand Availability of NeuroStar TMS Equipment Neuronetics, a medical technology company specializing in products for neurohealth disorders, has recently announced an exclusive partnership with Transformations Care Network (TCN), one of the largest mental health care providers in the country. This partnership aims to increase the availability of transcranial magnetic stimulation (TMS) equipment to patients by making Neuronetics the sole supplier of new NeuroStar TMS devices to TCN.As part of the agreement, Neuronetics will expand its NeuroStar TMS footprint within TCN, allowing more patients to benefit from this innovative treatment option. TMS is a n...
Brainsway Ltd is a medical device company that focuses on developing and commercializing advanced non-invasive treatments for brain disorders. Their business model revolves around the manufacturing and sale of deep transcranial magnetic stimulation (dTMS) systems, which are used in the treatment of major depressive disorder and obsessive-compulsive disorder, among other conditions. Through partnerships with healthcare providers and licensing agreements, Brainsway aims to expand the accessibility and adoption of their innovative technologies worldwide.
Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.
Envveno Medical Corporation is a medical technology company that focuses on developing and manufacturing innovative healthcare products. Their business model involves conducting extensive research and development to create cutting-edge medical solutions, collaborating with healthcare professionals and institutions to ensure effective implementation, and commercializing their products through strategic partnerships and distribution networks worldwide. By providing advanced medical technologies, Envveno Medical aims to improve patient outcomes and enhance the overall healthcare experience.
Vycor Medical Inc has a business model focused on developing and commercializing innovative medical devices and technologies in the healthcare industry.
Sources:
Neuronetics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Neuronetics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
